Olympia Diagnostics, Inc. products

A prognostic test kit quantitatively measures the expression levels of a panel of cancer recurrence-associated biomarkers in patient urine sample or biopsy tissue sample to predict cancer recurrence and patient survival

A diagnostic test kit quantitatively measures the expression levels of a panel of prostate cancer risk-associated biomarkers in patient urine sample or biopsy tissue sample to distinguish high-risk and aggressive prostate cancer needing immediate treatment from low-risk and indolent prostate cancer needing only surveillance

A diagnostic test kit quantitatively measures the expression levels of a panel of prostate cancer-specific biomarkers in patient urine sample or biopsy tissue sample to distinguish prostate cancer from benign patients or normal men.

A prognostic test kit quantitatively measures the expression levels of a panel of metastasis-specific biomarkers in patient urine sample or biopsy tissue sample to detect existing metastatic prostate cancer and predict prostate cancer that will become metastatic in the future